High-throughput gene sequencing assay development for hereditary nonpolyposis colon cancer

Clinical Colorectal Cancer

Volumn 4, Issue 4, 2004, Pages 275-279

  Huang, Donghui ^a   Chen, Christina ^a   Sun, Weimin ^a   Strom, Charles M ^a   Bender, Richard A ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Adenomatous polyposis coli; Germline mutations; Microsatellite instability; Mismatch repair genes; Polymerase chain reaction

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ANALYTIC METHOD; ARTICLE; BIOASSAY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXON; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC DATABASE; GERM LINE; HUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 10944270354     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2004.n.027     Document Type: Article

References (27)

1. American Cancer Society. Cancer Facts & Figures 2004. Atlanta, GA: ACS, 2004.
2. Winawer S, Fletcher R, Rex D, et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003; 124:544-560.
3. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348:919-932.
4. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-1456.
5. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89:1758-1762.
6. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
7. Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002; 62:3485-3492.
8. Kolodner RD, Tytell JD, Schmeits JL, et al. Germ-line MSH6 mutations in colorectal cancer families. Cancer Res 1999; 59:5068-5074.
9. Strom C, Huang S, Chen C, et al. Extensive Sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test. Genet Med 2003; 5:9-14.
10. International Collaborative Group on Hereditary Norpolyposis Colorectal Cancer. Mutation database. Available at: http://www.nfdht.nl/database/mdbchoice.htm. Accessed: November 20, 2003.
11. Nakagawa H, Yan H, Lockman J, et al. Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements. Cancer Res 2002; 62:4579-4582.
12. Liu B, Parsons RE, Hamilton SR, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994; 54:4590-4594.
13. Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995; 56:1060-1066.
14. Chen-Shtoyerman R, Theodor L, Harmati E, et al. Genetic analysis of familial colorectal cancer in Israeli Arabs. Hum Mutat 2003; 21:446-447.
15. Beck NE, Tomlinson IP, Homfray T, et al. Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. Hum Genet 1997; 99:219-224.
16. Merkelbach-Bruse S, Kose S, Losen I, et al. High throughput genetic screening for the detection of hereditary non-polyposis colon cancer (HNPCC) using capillary electrophoresis. Comb Chem High Throughput Screen 2000; 3:519-524.
17. Holinski-Feder E, Muller-Koch Y, Friedl W, et al. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (UNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 2001; 47:21-32.
18. Kurzawski G, Safranow K, Suchy J, et al. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2002; 51:89-100.
19. Nomura S, Sugano K, Kashiwabara H, et al. Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun 2000; 271:120-129.
20. Jakubowska A, Gorski B, Kurzawski G, et al. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes. Hum Mutat 2001; 17:52-60.
21. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121:198-213.
22. Bisgaard ML, Jager AC, Myrhoj T, et al. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation. Hum Mutat 2002; 20:20-27.
23. Wijnen J, van der Klift H, Vasen H, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20:326-328.
24. Taylor CF, Charlton RS, Burn J, et al. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 2003; 22:428-433.
25. Plaschke J, Ruschoff J, Schackert HK. Genomic rearrangements of hMSH6 contribute to the genetic predisposition in suspected hereditary non-polyposis colorectal cancer syndrome. J Med Genet 2003; 40:597-600.
26. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003; 138:560-570.
27. Ellison AR, Lofing J, Bitter GA. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 2001; 10:1889-1900.